Macan William Andrew's Insider Trades & SAST Disclosures
Macan William Andrew's most recent trade in Neuronetics Inc was a trade of 377 Common Stock done at an average price of $4.5 . Disclosure was reported to the exchange on March 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Macan William Andrew.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 4.48 per share. | 04 Mar 2025 | 377 | 526,805 (2%) | 0% | 4.5 | 1,689 | Common Stock |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 157,500 | 527,182 (2%) | 0% | 0 | Common Stock | |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 78,750 | 78,750 | - | - | Performance Restricted Stock Unit | |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 78,750 | 78,750 | - | - | Performance Restricted Stock Unit | |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 4.11 per share. | 14 Feb 2025 | 18,965 | 369,682 (1%) | 0% | 4.1 | 77,946 | Common Stock |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 3.83 per share. | 12 Feb 2025 | 12,175 | 388,647 (2%) | 0% | 3.8 | 46,630 | Common Stock |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 3.28 per share. | 10 Feb 2025 | 1,970 | 400,822 (2%) | 0% | 3.3 | 6,462 | Common Stock |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 135,000 | 135,000 | - | - | Performance Restricted Stock Unit | |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 0.82 per share. | 08 Oct 2024 | 1,541 | 402,792 (2%) | 0% | 0.8 | 1,264 | Common Stock |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 3.16 per share. | 28 Feb 2024 | 22,377 | 395,359 (2%) | 0% | 3.2 | 70,711 | Common Stock |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 15,000 | 404,333 (2%) | 0% | 0 | Common Stock | |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 2.94 per share. | 28 Feb 2024 | 6,026 | 389,333 (2%) | 0% | 2.9 | 17,716 | Common Stock |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 3.38 per share. | 14 Feb 2024 | 15,621 | 417,736 (2%) | 0% | 3.4 | 52,799 | Common Stock |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 90,000 | 438,742 (2%) | 0% | 0 | Common Stock | |
| Neuronetics Inc | Andrew William Macan | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 3.39 per share. | 05 Feb 2024 | 5,385 | 433,357 (2%) | 0% | 3.4 | 18,255 | Common Stock |
| Neuronetics Inc | Andrew William Macan | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 2.70 per share. | 19 Dec 2023 | 11,664 | 360,405 (1%) | 0% | 2.7 | 31,493 | Common Stock |
| Neuronetics Inc | Macan Andrew William | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 2.24 per share. | 19 Dec 2023 | 11,664 | 372,069 (1%) | 0% | 2.2 | 26,127 | Common Stock |
| Neuronetics Inc | Macan William Andrew | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 2.52 per share. | 19 Dec 2023 | 11,663 | 348,742 (1%) | 0% | 2.5 | 29,391 | Common Stock |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 2.13 per share. | 11 Jul 2023 | 2,645 | 385,202 (2%) | 0% | 2.1 | 5,634 | Common Stock |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 4.59 per share. | 07 Mar 2023 | 12,692 | 387,847 (2%) | 0% | 4.6 | 58,256 | Common Stock |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 5.90 per share. | 15 Feb 2023 | 11,974 | 411,583 (2%) | 0% | 5.9 | 70,647 | Common Stock |
| Neuronetics Inc | William Andrew Macan | EVP, GC, CCO and CS | Sale of securities on an exchange or to another person at price $ 5.91 per share. | 15 Feb 2023 | 11,044 | 400,539 (2%) | 0% | 5.9 | 65,270 | Common Stock |
| Neuronetics Inc | William Andrew Macan | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 90,000 | 423,557 (2%) | 0% | 0 | Common Stock | |
| Neuronetics Inc | William Andrew Macan | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 5.99 per share. | 07 Feb 2023 | 5,162 | 333,557 (1%) | 0% | 6.0 | 30,920 | Common Stock |
| Neuronetics Inc | William Andrew Macan | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 5.96 per share. | 23 Jan 2023 | 16,046 | 338,719 (1%) | 0% | 6.0 | 95,634 | Common Stock |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Sale of securities on an exchange or to another person at price $ 2.93 per share. | 07 Oct 2022 | 1,547 | 354,841 (1%) | 0% | 2.9 | 4,533 | Common Stock |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Sale of securities on an exchange or to another person at price $ 2.82 per share. | 07 Oct 2022 | 76 | 354,765 (1%) | 0% | 2.8 | 214 | Common Stock |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Sale of securities on an exchange or to another person at price $ 3.60 per share. | 08 Jul 2022 | 2,746 | 356,388 (1%) | 0% | 3.6 | 9,886 | Common Stock |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Sale of securities on an exchange or to another person at price $ 2.85 per share. | 07 Mar 2022 | 11,489 | 359,271 (1%) | 0% | 2.8 | 32,730 | Common Stock |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Sale of securities on an exchange or to another person at price $ 3.14 per share. | 07 Mar 2022 | 137 | 359,134 (1%) | 0% | 3.1 | 430 | Common Stock |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 166,562 | 370,760 (1%) | 0% | 0 | Common Stock | |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Sale of securities on an exchange or to another person at price $ 3.26 per share. | 07 Feb 2022 | 4,716 | 204,213 (1%) | 0% | 3.3 | 15,393 | Common Stock |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Sale of securities on an exchange or to another person at price $ 3.27 per share. | 07 Feb 2022 | 15 | 204,198 (1%) | 0% | 3.3 | 49 | Common Stock |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Sale of securities on an exchange or to another person at price $ 3.52 per share. | 24 Jan 2022 | 11,562 | 208,929 (1%) | 0% | 3.5 | 40,698 | Common Stock |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2021 | 10,000 | 220,491 (1%) | 0% | 0 | Common Stock | |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Sale of securities on an exchange or to another person at price $ 14.61 per share. | 08 Jul 2021 | 2,591 | 210,491 (1%) | 0% | 14.6 | 37,860 | Common Stock |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Sale of securities on an exchange or to another person at price $ 14.65 per share. | 09 Mar 2021 | 8,537 | 213,082 (1%) | 0% | 14.6 | 125,067 | Common Stock |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 33,166 | 221,619 (1%) | 0% | 0 | Common Stock | |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 10,000 | 10,000 | - | - | Perfornance Restricted Stock Unit | |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Sale of securities on an exchange or to another person at price $ 21.28 per share. | 22 Jan 2021 | 12,696 | 188,453 (1%) | 0% | 21.3 | 270,171 | Common Stock |
| Neuronetics Inc | William Andrew Macan | Sr. VP, GC, CCO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2020 | 18,750 | 201,149 (1%) | 0% | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges